Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000471546 | SCV000560893 | likely benign | Costello syndrome | 2023-12-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002431368 | SCV002730718 | likely benign | Cardiovascular phenotype | 2021-12-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003392297 | SCV004134986 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | HRAS: BP4, BP7 |
Prevention |
RCV003899987 | SCV004709366 | likely benign | HRAS-related disorder | 2020-09-30 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |